Abstract:Cyclic nucleotides are important signaling molecules that play many critical physiological roles including controlling cell fate and development, regulation of metabolic processes, and responding to changes in the environment. Cyclic nucleotides are also pivotal regulators in immune signaling, orchestrating intricate processes that maintain homeostasis and defend against pathogenic threats. This review provides a comprehensive examination of the pharmacological potential of cyclic nucleotide signaling pathways within the realm of immunity. Beginning with an overview of the fundamental roles of cAMP and cGMP as ubiquitous second messengers, this review delves into the complexities of their involvement in immune responses. Special attention is given to the challenges associated with modulating these signaling pathways for therapeutic purposes, emphasizing the necessity for achieving cell-type specificity to avert unintended consequences. A major focus of the review is on the recent paradigm-shifting discoveries regarding specialized cyclic nucleotide signals in the innate immune system, notably the cGAS–STING pathway. The significance of cyclic dinucleotides, exemplified by 2′3′-cGAMP, in controlling immune responses against pathogens and cancer, is explored. The evolutionarily conserved nature of cyclic dinucleotides as antiviral agents, spanning across diverse organisms, underscores their potential as targets for innovative immunotherapies. Findings from the last several years have revealed a striking diversity of novel bacterial cyclic nucleotide second messengers which are involved in antiviral responses. Knowledge of the existence and precise identity of these molecules coupled with accurate descriptions of their associated immune defense pathways will be essential to the future development of novel antibacterial therapeutic strategies. The insights presented herein may help researchers navigate the evolving landscape of immunopharmacology as it pertains to cyclic nucleotides and point toward new avenues or lines of thinking about development of therapeutics against the pathways they regulate.

Synthesis of All Possible Canonical (3 '-5 '-Linked) Cyclic Dinucleotides and Evaluation of Riboswitch Interactions and Immune-Stimulatory Effects

Chemical Synthesis, Purification, and Characterization of 3′-5′-linked Canonical Cyclic Dinucleotides (Cdns)

Structural Flexibility and Conformation Features of Cyclic Dinucleotides in Aqueous Solutions

Highly Efficient Preparation of Cyclic Dinucleotides Via Engineering of Dinucleotide Cyclases in Escherichia Coli

Distinct Dynamical and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.

Design, Synthesis and Biological Evaluation of (2′,5′ and 3′5′-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING)

Chemical Evolution of Cyclic Dinucleotides: Perspective of the Analogs and Their Preparation

Computational and NMR Spectroscopy Insights into the Conformation of Cyclic Di-Nucleotides.

Design and Synthesis of Cyclic Dinucleotide Analogues Containing Triazolyl C-Nucleosides

Design, Synthesis and Systematic Evaluation of All Possible Cyclic Dinucleotides (cdns) That Activate Human Stimulator of Interferon Genes (STING) Variants

Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants

Exploration of the Binding Mechanism of Cyclic Dinucleotide Analogs to Stimulating Factor Proteins and the Implications for Subsequent Analog Drug Design

Synthesis of Original Cyclic Dinucleotide Analogues Using the Sulfo-click Reaction

2 ',3 '-Cyclic GMP-AMP Dinucleotides for STING-Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis

Pharmacological potential of cyclic nucleotide signaling in immunity

Structural Insights into Recognition of C-Di-amp by the Ydao Riboswitch

Transcriptome-based Characterization of 3’2’-Cgamp Signaling Mediated Immune Responses

Synthesis of c-di-GMP analogs modified by ganciclovir and biological activity to induce type Ⅰ interferon

Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING

Signal Transduction of Streptococci by Cyclic Dinucleotide Second Messengers

Cyclic ADP ribose isomers: Production, chemical structures, and immune signaling